RAFFERTY ASSET MANAGEMENT, LLC – Halozyme Therapeutics, Inc. Transaction History
RAFFERTY ASSET MANAGEMENT, LLC portfolio value:
$6.61M
portfolio value
RAFFERTY ASSET MANAGEMENT, LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +91.96% | 80.14K shares | 2.78M | $39.54 | 167.29K |
| Q2 2022 | share | Decrease | -43.41% | -66.84K shares | -2.30M | $44 | 87.15K |
| Q1 2022 | share | Increase | +0.75% | 1.15K shares | -5K | $39.88 | 153.99K |
| Q4 2021 | share | Increase | +102.29% | 77.28K shares | 3.07M | $40.32 | 152.84K |
| Q3 2021 | share | Increase | +23.94% | 14.59K shares | 306K | $40.68 | 75.55K |
| Q2 2021 | share | Decrease | -18.81% | -14.12K shares | -362K | $45.41 | 60.96K |
| Q1 2021 | share | Increase | +230.63% | 52.37K shares | 2.16M | $41.69 | 75.08K |
| Q4 2020 | share | Decrease | -69.04% | -50.64K shares | -958K | $42.71 | 22.71K |
| Q3 2020 | share | Increase | +75.29% | 31.50K shares | 806K | $26.28 | 73.35K |
| Q2 2020 | share | Increase | 0.00% | 41.84K shares | 1.12M | $26.81 | 41.84K |
| Q1 2020 | share | Decrease | -100.00% | -81.54K shares | -1.44M | $17.99 | 0 |
| Q4 2019 | share | Decrease | -47.92% | -75.03K shares | -983K | $17.73 | 81.54K |
| Q3 2019 | share | Increase | +15.72% | 21.27K shares | 104K | $15.51 | 156.57K |
| Q2 2019 | share | Increase | +28.19% | 29.75K shares | 626K | $17.18 | 135.30K |
| Q1 2019 | share | Increase | 0.00% | 105.54K shares | 1.69M | $16.1 | 105.54K |